Mode
Text Size
Log in / Sign up

IgG4-related disease

Part of IgG4-RD

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for IgG4-related disease

2 trials tracked for IgG4-related disease.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Safety and Efficacy of Abatacept in IgG4-Related Disease Completed
  2. Phase 2 Zanubrutinib in Patients With IgG4-Related Disease Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across IgG4-RD

Related studies from across the IgG4-RD family.

Case report and literature review on IgG4-related disease misdiagnosed as pancreatic cancer in a 70-year-old male
Rheumatology Meta-analysis
Case report and literature review on IgG4-related disease misdiagnosed as pancreatic cancer in a 70-year-old male A 70-year-old man avoided unnecessary surgery after doctors found a treatable autoimmune condition
This case report and literature review examines a 70-year-old male patient with IgG4-related autoimmune pancreatitis initially suspected as …
A 70-year-old man with a pancreatic mass was found to have a treatable autoimmune disease, sparing him from unnecessary surgery.
Systematic review of anti-IL-5 biologics in hypereosinophilic syndrome kidney disease reports low certainty evidence
Allergy & Immunology Meta-analysis
Systematic review of anti-IL-5 biologics in hypereosinophilic syndrome kidney disease reports low certainty evidence New Clues Help Doctors Spot Kidney Trouble in Rare Blood Disease
This systematic review with narrative synthesis evaluates anti-IL-5 and IL-5Rα biologics in patients with histologically confirmed hypereosi…
A new review shows kidney issues in rare blood disorders are tricky to diagnose but may respond well to specific drugs.
Metabolomics analysis reveals distinct B-cell metabolic signatures in IgG4-RD patients compared to healthy controls
Gastroenterology Cohort
Metabolomics analysis reveals distinct B-cell metabolic signatures in IgG4-RD patients compared to healthy controls Metabolic changes found in B cells of IgG4-related disease patients
This cohort study analyzed B cells from 32 IgG4-RD patients and 31 healthy controls using UPLC-MS/MS-based metabolomics.
A specific panel of 14 chemical markers inside immune cells accurately identifies patients with IgG4-related disease from healthy people.